A fraction enriched in the minor components of the kanamycin complex was prepared from a commercial sample. The enriched fraction was subjected to Amberlite CG-50 and Dowex 1-X2 column chromatography. Two minor components were isolated in addition to the known A, B, and C components. These congeners were identified as paromamine and 6-o-(3-amino-3-deoxy-a-Dglucopyranosyl)-deoxystreptamine. The identification was based on degradation and mass spectral studies.
bottom: R = NH,, R, = OH (I); R = NH2, R1 = NH2 (II); and R -OH, R, = NH2 (III). These can be differentiated by paper chromatography (10) , ion-exclusion chromatography (5, 10), and gas-liquid chromatography (GLC) (11) . Two thin-layer chromatography systems for the detection of kanamycin B in commercial kanamycin were developed by Dubost et al. (3) . Kanamycin B showed a spot with a lower R, value than the A component in both chromatography systems. For commercial samples a third spot (with higher R, value than kanamycin A) was visible in the system using 15% aqueous KH2PO , on precoated (Merck) plates (Fig, 1) .
The second system gave a similar picture. The present report deals with the isolation and identification of the products responsible for this spot. It should be noted that in these systems kanamycin C has the same R, value as kanamycin A.
MATERIALS AND METHODS General. The solvent systems for thin-layer chromatography (3) consisted of 15% aqueous KH,PO, and of a mixture of 10% aqueous NaH2PO4-methanolethyl acetate (8:7:3) . Precoated silica gel F-254 plates (Merck) were used in the first system, and silica gel G plates were used in the second. Ninhydrinstannous chloride (1) was used for detection. Paper chromatography was performed on Whatman no. 1 paper by using a solvent system described by Majumdar and Majumdar (8) consisting of methyl ethyl keton-t-butanol-methanol-6.5 N ammonium hydroxide (16:3:1:6). Technical details on ion-exclusion (Dowex 1-X2) column chromatography are given in a previous publication (13) . For all separations reported in the present paper, a column with a diameter of 3 cm and a height of 64 cm was used. The flow rate was 350 ml/h, and the sample weight varied from 20 to 50 mg. Column effluents were evaporated under reduced pressure at a temperature of 40 C. N-acetylated derivatives were obtained by suspending 10 mg of the free bases into a mixture of 2 ml of anhydrous methanol and 0.4 ml of acetic anhydride. After 15 h at room temperature, the solvent was evaporated in vacuo, and the major part of the anhydride was removed by adding 1 ml of benzene and evaporating under reduced pressure. The last traces of acetic anhydride were decomposed by dissolving the residue in a mixture of 2 ml of methanol saturated with ammonia. The solutions were kept in the refrigerator for 4 h, and then evaporated and dried in vacuo over P20s.
N-acetylated samples were 0-silylated for 2 h with 0.5 to 1 ml of Tri-Sil Z, a commercial trimethylsilylating agent containing 1.5 meq of N-trimethylsilylimidazole per ml in pyridine. GLC was performed on a glass column (length 150 cm, outside diameter 0.6 cm) filled with 3% QF-1 on chromosorb W at a temperature of 165 C. Mass spectrometry was carried out on an AEI MS12 spectrometer by direct insertion into the ion source, operated at a temperature of 150 to 170 C for derivatives of compounds 2 and 4 and 200 to 220 C for kanamycin derivatives. The O-trimethylsilyl-N-acetyl derivatives of the methylhexosaminides were identified by a GLC-mass spectrometry combination technique (membrane separator operated at 200 C).
Kanamycin B (sulfate) was obtained from Bristol Laboratories, Syracuse, N.Y. Kanamycin C (free base) was obtained from Meiji Seika Kaisha Ltd., Kawasaki, Japan. Paromamine (IV) was prepared by methanolysis of paromomycine (4), and 6-0-(3-aminoa-D-glucopyranosyl)-deoxystreptamine (V) was ob- Mass spectra of the O-trimethylsilyl-N-acetyl derivatives of components 2 and 4 were quite similar and afforded information concerning their structure. Both compounds showed a molecular ion at m/e 809 and diagnostic peaks at m/e 794 (M-CH.), 420, and 373. Fragment ions 420 and 373 indicated the presence of an aminohexopyranose and a deoxystreptamine moiety, respectively. These data suggested that both compounds, diagrammed below, are isomeric hexosaminyldeoxystreptamines:
C,H7O(NHAc)(OTMS) 3 .-04 C6H7(NHAc)2(OTMS)2 hexosamine moiety (mle 420) tography. Thin-layer chromatography of the fractions containing the latter components showed that they were responsible for the spot with the highest R, value which was observed in the chromatograms of commercial samples of kanamycin. The chromatogram given in Fig. 2 shows that ion-exclusion chromatography is not an adequate method for the isolation of components 2 and 4 in a pure state, since their retention volumes were similar to that of kanamycin B (peak 3). Therefore, 1 g of the enriched sample was separated on an Amberlite CG-50 column. In this chromatography system, originally described for the separation of neomycins B and C (G. Nomine and L. Penasse, Chem.
Abstr. 58:3277, 1963), the mixture is absorbed on the carboxylic resin in the ammonium form. Elution is carried out with dilute ammonium The nature of the hexosamine fragment could not be derived from the spectrum data. Therefore, the N-acetyl derivatives of both components were subjected to acid methanolysis. The reaction mixture, which contained deoxystreptamine, the a-and ,B-methylhexosaminides, and other degradation products was fractionated by ion-exclusion column chromatography. The fractions containing the a-and ,-methylhexosaminides were o-silylated, Nacetylated, and analyzed by GLC-mass spectrometry. Both GLC retention times and mass spectrum data (as compared'with the' refere'nce materials, a-and,-methyl-o-trimethylsilyl:2-acetamido-2-deoxy-D-glucopyranoside)I revealed that the hexosamine fragment of component 2 was a 2-amino-2-deoxyglucose. The spectra of the a-and ,-anomers were quite similar: it is reasonable to suggest that component 2 is identical to IV. Identity of component 2 with paromamine was deduced from retention time and R, value, observed in ion-exclusion and paper chromatography (8) . It should be noted that paromamine may be obtained by partial hydrolysis of paromomycin (4) and of kanamycin C (9) .
The hexosamine moiety of component 4 was identified as 3-amino-3-deoxyglucose in a simi- 4, 1973 lar way. The fragment ions mentioned for the O-trimethylsilyl derivatives of the a-and ,Banomers of methyl-2-acetamido-2-deoxyglucopyranoside were also found in the mass spectra of the methyl-O-trimethylsilyl-3-acetamido-3-deoxyglucopyranosides. The spectra of the latter compounds, however, showed a greater relative intensity for the m/e 173 ion and a very reduced intensity for the m/e 204 ion. These differences can be explained on the basis that the acetamido function in the 3-position enhances thg probability for the production of a TMSOCH-CHNHAc ion (mle 173) relative to a 2-acetamido function. The reverse is true for the analogous TMSO(,H-CHOTMS ion (m/e 204).
In analogy to the a-D configuration of the 3-aminoglucose moiety and the 6-position of its glucosidic linkage to deoxystreptamine in kanamycin A, the most probable structure of 4 is that of a 6-0-(3-amino-3-deoxy-a-D-glucopyranosyl)-deoxystreptamine (V). Confirmation of this structure for compound 4 was obtained by comparison of the latter with V in ion-exclusion and paper chromatography (8) . The reference compound (V) was obtained by partial hydrolysis of kanamycin A (6).
Since both IV and V are structurally related to the kanamycins, they can be produced during fermentation and can be regarded as congeners. However, their presence may be due to hydrolysis of the kanamycins during isolation or purification.
